Literature DB >> 21507938

Amyloid-β annular protofibrils evade fibrillar fate in Alzheimer disease brain.

Cristian A Lasagna-Reeves1, Charles G Glabe, Rakez Kayed.   

Abstract

Annular protofibrils (APFs) represent a new and distinct class of amyloid structures formed by disease-associated proteins. In vitro, these pore-like structures have been implicated in membrane permeabilization and ion homeostasis via pore formation. Still, evidence for their formation and relevance in vivo is lacking. Herein, we report that APFs are in a distinct pathway from fibril formation in vitro and in vivo. In human Alzheimer disease brain samples, amyloid-β APFs were associated with diffuse plaques, but not compact plaques; moreover, we show the formation of intracellular APFs. Our results together with previous studies suggest that the prevention of amyloid-β annular protofibril formation could be a relevant target for the prevention of amyloid-β toxicity in Alzheimer disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21507938      PMCID: PMC3121356          DOI: 10.1074/jbc.M111.236257

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

1.  Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease.

Authors:  C A McLean; R A Cherny; F W Fraser; S J Fuller; M J Smith; K Beyreuther; A I Bush; C L Masters
Journal:  Ann Neurol       Date:  1999-12       Impact factor: 10.422

2.  Assembly of amyloid protofibrils via critical oligomers--a novel pathway of amyloid formation.

Authors:  A J Modler; K Gast; G Lutsch; G Damaschun
Journal:  J Mol Biol       Date:  2003-01-03       Impact factor: 5.469

3.  Evidence for membrane thinning effect as the mechanism for peptide-induced pore formation.

Authors:  Fang-Yu Chen; Ming-Tao Lee; Huey W Huang
Journal:  Biophys J       Date:  2003-06       Impact factor: 4.033

Review 4.  Expression of normal sequence pathogenic proteins for neurodegenerative disease contributes to disease risk: 'permissive templating' as a general mechanism underlying neurodegeneration.

Authors:  J Hardy
Journal:  Biochem Soc Trans       Date:  2005-08       Impact factor: 5.407

Review 5.  Opinion: What is the role of protein aggregation in neurodegeneration?

Authors:  Christopher A Ross; Michelle A Poirier
Journal:  Nat Rev Mol Cell Biol       Date:  2005-11       Impact factor: 94.444

6.  Models of membrane-bound Alzheimer's Abeta peptide assemblies.

Authors:  Yinon Shafrir; Stewart Durell; Nelson Arispe; H Robert Guy
Journal:  Proteins       Date:  2010-10-11

7.  GM1-ganglioside-induced Abeta assembly on synaptic membranes of cultured neurons.

Authors:  Naoki Yamamoto; Yuko Fukata; Masaki Fukata; Katsuhiko Yanagisawa
Journal:  Biochim Biophys Acta       Date:  2007-01-20

8.  Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease.

Authors:  L F Lue; Y M Kuo; A E Roher; L Brachova; Y Shen; L Sue; T Beach; J H Kurth; R E Rydel; J Rogers
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

9.  Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice.

Authors:  Lauren M Billings; Salvatore Oddo; Kim N Green; James L McGaugh; Frank M LaFerla
Journal:  Neuron       Date:  2005-03-03       Impact factor: 17.173

Review 10.  Common mechanisms of amyloid oligomer pathogenesis in degenerative disease.

Authors:  Charles G Glabe
Journal:  Neurobiol Aging       Date:  2006-02-14       Impact factor: 4.673

View more
  59 in total

1.  Caspase-Cleaved Tau Impairs Mitochondrial Dynamics in Alzheimer's Disease.

Authors:  María José Pérez; Katiana Vergara-Pulgar; Claudia Jara; Fabian Cabezas-Opazo; Rodrigo A Quintanilla
Journal:  Mol Neurobiol       Date:  2017-01-13       Impact factor: 5.590

Review 2.  Alzheimer's disease: pathophysiology and applications of magnetic nanoparticles as MRI theranostic agents.

Authors:  Houshang Amiri; Kolsoum Saeidi; Parvin Borhani; Arash Manafirad; Mahdi Ghavami; Valerio Zerbi
Journal:  ACS Chem Neurosci       Date:  2013-09-26       Impact factor: 4.418

Review 3.  The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes.

Authors:  Iryna Benilova; Eric Karran; Bart De Strooper
Journal:  Nat Neurosci       Date:  2012-01-29       Impact factor: 24.884

Review 4.  The neglected co-star in the dementia drama: the putative roles of astrocytes in the pathogeneses of major neurocognitive disorders.

Authors:  W K Jo; A C K Law; S K Chung
Journal:  Mol Psychiatry       Date:  2014-01-07       Impact factor: 15.992

5.  In silico cross seeding of Aβ and amylin fibril-like oligomers.

Authors:  Workalemahu M Berhanu; Fatih Yaşar; Ulrich H E Hansmann
Journal:  ACS Chem Neurosci       Date:  2013-09-19       Impact factor: 4.418

6.  Successive Stages of Amyloid-β Self-Assembly Characterized by Solid-State Nuclear Magnetic Resonance with Dynamic Nuclear Polarization.

Authors:  Alexey Potapov; Wai-Ming Yau; Rodolfo Ghirlando; Kent R Thurber; Robert Tycko
Journal:  J Am Chem Soc       Date:  2015-06-19       Impact factor: 15.419

7.  Ion Channel Formation by Amyloid-β42 Oligomers but Not Amyloid-β40 in Cellular Membranes.

Authors:  David C Bode; Mark D Baker; John H Viles
Journal:  J Biol Chem       Date:  2016-12-07       Impact factor: 5.157

8.  NMR-based site-resolved profiling of β-amyloid misfolding reveals structural transitions from pathologically relevant spherical oligomer to fibril.

Authors:  Yiling Xiao; Isamu Matsuda; Masafumi Inoue; Tomoya Sasahara; Minako Hoshi; Yoshitaka Ishii
Journal:  J Biol Chem       Date:  2019-11-26       Impact factor: 5.157

Review 9.  Molecular Structure of Aggregated Amyloid-β: Insights from Solid-State Nuclear Magnetic Resonance.

Authors:  Robert Tycko
Journal:  Cold Spring Harb Perspect Med       Date:  2016-08-01       Impact factor: 6.915

10.  Mutations and seeding of amylin fibril-like oligomers.

Authors:  Nathan A Bernhardt; Workalemahu M Berhanu; Ulrich H E Hansmann
Journal:  J Phys Chem B       Date:  2013-12-02       Impact factor: 2.991

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.